LH - CIK 0000920148
The table below shows LABORATORY CORP OF AMERICA HOLDINGS's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $1.64B | $1.59B | $1.33B | $1.96B | $3.11B | $2.14B |
| Capital expenditure | $434.50M | $489.90M | $453.60M | $429.30M | $421.50M | $381.70M |
| Investing cash flow | -$1.19B | -$1.37B | -$1.17B | -$1.65B | -$884.60M | -$643.20M |
| Dividends paid | $240.70M | $243.10M | $254.00M | $195.20M | - |
LABORATORY CORP OF AMERICA HOLDINGS reported operating cash flow of $1.64B for fiscal year 2025. That is up 3.4% from $1.59B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $1.20B (FY 2016) to $1.64B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $450.00M | $250.10M | $1.00B | $1.10B | $1.67B | $100.00M |
| Financing cash flow | -$1.46B | $779.90M | -$59.30M | -$1.32B | -$2.07B | -$517.40M |